Delivery Order SPE2DB22D1106-SPE2DB23FEJB3
- Not listed
- This federal contract award, with an ID of SPE2DX15D1053|SPE2DX24F6NHR, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $1,362.12 fixed-price delivery order is for the supply of 4564829344 units of the pharmaceutical product BUPRENORPHINE-NALOX 2-0.5MG FM 30S. The contract has an ultimate completion date of June 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of buprenorphine 0.3 mg/mL vials to the Defense Logistics Agency (DLA). The $1,041.75 firm-fixed-price delivery order is not set aside and was awarded on July 2, 2024 with a completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical as the primary vehicle to provide a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,481.50 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $4,722.50 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,044.96 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract covers the provision of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,120.69 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 5, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,193.82 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) and has a period of performance through June 2021. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,143.25 issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the provision of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,043.28 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565625305 - Naloxone Hydrochloride, a critical medication used to reverse opioid overdoses. The award is not a set-aside contract. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts with federal agencies, including a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB23FEJB3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,361.42 delivery order contract is for the supply of Buprenorphine-Nalox 8-2mg film, a medication used to treat opioid dependence. The contract has a completion date of May 18, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 5/17/23 |